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license (http://creativecommons.org/Summary Central dual-energy X-ray absorptiometry (DXA) of the lumbar spine and proximal
femur is the preferred method for bone mineral density (BMD) testing. Despite the fracture risk
statistics, osteoporosis testing with DXA remains underused. However, BMD can also be as-
sessed with quantitative computed tomography (QCT) that may be available when access to
DXA is restricted. For patients undergoing a primary CT study of the abdomen or pelvis, a po-
tential opportunity exists for concurrent BMD screening by QCT without the need for any addi-
tional imaging, radiation exposure, or patient time.
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Central dual-energy X-ray absorptiometry (DXA) of the
lumbar spine and proximal femur is the preferred method
for bone mineral density (BMD) testing. Despite the fracture
risk statistics, osteoporosis testing with DXA remains un-
derused [1,2]. However, BMD can also be assessed with
other radiologic imaging tools, such as quantitative
computed tomography (QCT) that may be available when
access to DXA is restricted [3]. Originally, QCT was devel-
oped as a methodology using single thick (around 10 mm)




hors. Published by Elsevier (Singa
licenses/by-nc-nd/4.0/).the cortical end plates. However, this mode of operation
has now been largely superseded by the use of volume
images covering regions of interest at the spine or hip.
For patients undergoing screening CT colonography
(CTC), a potential opportunity exists for concurrent BMD
screening by QCT without the need for any additional im-
aging, radiation exposure, or patient time [4]. In addition,
there are a number of indications for CT imaging for which
there is a large overlap between the need for a CT scan and
a patient having risk factors for osteoporosis. By utilizing
volume-based QCT methodology rather than the older
single-slice protocols, use may also be made of these CT
images for BMD measurement by QCT [5,6]. Such dual use of
CT images could increase screening rates or, alternatively,
preclude the need for DXA screening in some individuals.
Previous studies combining standard CT imaging and
QCT have generally focused on BMD measurement at thepore) Pte Ltd. This is an open access article under the CC BY-NC-ND
Figure 1 Simultaneous calibration involves the patient lying
on top of a calibration phantom, in this case, a five-phase
CanneGenant phantom. A gel-filled bolus bag fills the air gap
between the phantom and lumbar region.
Figure 2 Single-slice quantitative computed tomography
protocols typically use a series of three to four 10-mm slices
angled parallel to the vertebral end plates.
Dual use of computed tomography scans 179lumbar spine [7,8] for which QCT provides a volumetric
BMD measure of the trabecular vertebral bone in isolation.
This can have an advantage of superior sensitivity due to
the higher turnover rate of trabecular bone [9], but QCT T-
scores on average are somewhat lower than DXA T-scores
for the same age, and the established World Health Orga-
nization (WHO) classification of osteoporosis by DXA T-
score is not appropriate [10]. By contrast, at the proximal
femur, QCT three-dimensional (3D) data may be used to
derive a projectional two-dimensional (2D) image of the
proximal femur, and this image may be analysed using
standard DXA region of interests (ROIs) to determine DXA-
equivalent “computed tomography X-ray absorptiometry
(CTXA)” areal BMD (aBMD) values in g/cm2 [11]. Using this
method, the WHO T-score classifications may be applied
and the aBMD measures may be included in FRAX
calculations.
The workflow associated with such dual use of CT scans
may be improved using “phantom-less” or “asynchronous”
calibration methods, so that the BMD measurement does
not need to be planned in advance of the CT scan. In
addition, using such methods, it is possible to make use of
archived CT scans retrospectively [12]. Finally, the use of
intravenous (IV) contrast-enhanced CT images for QCT is
usually contraindicated and a measurement bias has been
shown at the spine [13]. However, some recent studies
suggest that for measurements made at the hip, the mea-
surement difference due to contrast enhancement may not
be clinically significant, further widening the utility of CT
scans for BMD measurement [14].
Standard QCT
QCT may be performed on any CT scanner with the use of
a calibration phantom and dedicated analysis software.
The patient is usually examined in the supine position,
lying on the phantom, usually with a water- or gel-filled
cushion between the phantom and patient to avoid CT
reconstruction (Figure 1). Calibration phantoms are
required to transform the attenuation measured in
Hounsfield units into BMD values. When the patient and
phantom are examined at the same time, the process may
be described as “simultaneous calibration”. Three of the
most frequently used calibration phantoms for this pur-
pose are the solid-state CanneGenant phantom (Mindways
Software Inc., Austin, TX, USA) containing five potassium
phosphate-equivalent density phases; the five-phase solid-
state calcium hydroxyapatite phantoms developed by
Image Analysis Inc. (Columbia, KY, USA); and the phantom
developed by Kalender et al [15] utilizing two calcium
hydroxyapatite phases. This latter phantom is used by
Siemens (Siemens Healthcare, Erlangen, Germany) for
their commercial QCT product. BMD measurements from
different types of calibration phantoms are not inter-
changeable, unless a cross-calibration calculation is
performed.
Single-slice QCT
Single-slice QCT was the original QCT methodology, which
was developed on single-slice CT scanners for trabecularBMD measurements at the lumbar spine. Using the standard
methodology, single sections of three to four consecutive
vertebrae from T11 to L4 are scanned [16] (Figure 2). A
typical acquisition involves 10-mm slice thickness with a
gantry tilt used to derive midvertebral sections parallel to
the vertebral end plates. The gantry tilt is selected inter-
actively by the technologist from the lateral scout view.
Single-slice QCT protocols generally have radiation doses
that are higher than those of DXA, although these doses are
smaller than many other radiographic procedures. Low-
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150e200 mAs) result in effective doses of less than 200 mSv
[16]. By way of comparison, DXA has radiation doses in the
order of 10e15 mSv for the spine and hip. However, QCT has
lower exposure doses than many other standard radiology
procedures: an anteroposterior lumbar spine radiograph
has a dose of 700 mSv and a standard abdominal CT has an
exposure dose of the order of 8000 mSv [17].
Although radiation exposure dose can be substantially
lower with single-slice QCT compared with volumetric QCT
(vQCT), which is described in the next section, a substantial
disadvantage with single-slice BMD analysis by 2D QCT is the
lower precision compared with that of DXA (1.5e4% vs. 1%),
which results in a larger least significant change required to
detect significant changes in BMD (6e11% vs. 3%). This,
however, is partially offset by the fact that metabolic ac-
tivity of trabecular bone is higher and that even lower
precision single-slice QCT is usually adequate to monitor
longitudinal changes that are in the same range as those
found with DXA.
Of course, it should be noted that, in the context of
opportunistic screening by the dual use of a CT scan,
exposure dose is not an issue because a CT scan has already
been performed for some other purpose. However,
although a single, angled slice could be extracted from a
volumetric CT of the abdomen for secondary computation
of BMD at the spine, the lower precession means that vQCT
is the favoured method.
Volumetric QCT
vQCT or 3D QCT has increased precision and is easier to
perform compared with single-slice QCT. A contiguous vol-
ume with a slice thickness of 1e3 mm with no CT gantry tilt
is typically scanned (Figure 3). At the lumbar spine,Figure 3 For three-dimensional volumetric quantitative
computed tomography protocols, a contiguous volume with a
slice thickness of 1e3 mm with no computed tomography
gantry tilt is typically scanned.protocols usually include only two vertebrae between T11
and L4, often L1 and L2, to reduce dose while achieving
measurement precision noninferior or superior to that re-
ported for single-slice QCT [16]. Typical values are in the
order of 80e120 kVp and between 50 and 200 mAs. Using
these parameters, the dose has been estimated using phar-
maceutical clinical trials protocols with 1-mm slice width to
be as high as 1.5 mSv for the spine and 2.5e3 mSv for the hip
[16]. For a fixed noise level, exposure, and consequently
dose, decreases inversely to slice thickness. Thus, doses of
under 1 mSv for 2.5e3.0-mm slice thicknesses commonly
used for clinical QCT are achievable. This is consistent with
lower doses on the order of 0.3e0.6 mSv for the spine
described by one of the CT manufacturers [18]. The preci-
sion for trabecular BMD measurements by vQCT is superior to
2D slice-based QCT, which is comparable with that of DXA
[16].
At the spine, QCT provides a volumetric BMD measure of
the trabecular vertebral bone in isolation (Figure 4). This
can have an advantage of superior sensitivity because of
the higher turnover rate of trabecular bone [9] and can also
avoid the confounding effects of joint-space narrowing,
osteophytes, aortic calcification, and other extraosseous
calcification that can artificially raise a DXA spine BMD
measurement [19e21]. However, the measurement of iso-
lated trabecular bone means that QCT T-scores are some-
what lower, on average, than DXA T-scores for the same age
[10], and the established WHO classification of osteoporosis
by DXA T-score is not appropriate. To facilitate the inter-
pretation of QCT spine results, the American College of
Radiology has in 2008 and 2013 published guidelines for the
performance of QCT [22]; based on these guidelines, volu-
metric trabecular BMD values from 120 mg/cm3 to 80 mg/
cm3 are defined as osteopenia and BMD values less than
80 mg/cm3 as osteoporosis.Projectional QCT: Hip
By contrast, at the proximal femur, 3D QCT data may be
used to derive a projectional 2D image of the proximal
femur (Figure 5), and this image may be analysed using
standard DXA ROIs to determine DXA-equivalent CTXA aBMD
values in g/cm2. Because the correlations between these
calculated BMD values of the proximal femur and those
obtained by DXA are extremely high, the WHO T-scoreFigure 4 At the spine, a region of interest used measures the
trabecular bone mineral density in isolation.
Figure 5 At the hip, computed tomography can produce
projectional data that are used with region of interests similar
to dual-energy X-ray absorptiometry (DXA), to provide DXA-
equivalent areal bone mineral density measurements and T-
scores.
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jectional hip BMD values has been found to be slightly
better than DXA in the same patients [10,13,22], probably
because of hip rotation being performed by software rather
than at the time of acquisition. Areal CTXA BMD measure-
ments from hip QCT are included in the FRAX tool [24], and
hip BMD conversion equations are available between Holo-
gic and Lunar DXA and QCT. In addition, the 2008 and 2013
American College of Radiology QCT Practice Guidelines
state that QCT at the hip also provides aBMD with DXA-
equivalent T-scores.Calibration methods
The usual protocol of scanning a calibration phantom with a
patient for QCT can be problematic for the dual use of CT
images. In particular, the requirement for phantom place-
ment must be known prior to scanning the patient, and the
workflow including the patient positioning associated with
a regular CT imaging protocol must be altered. There is,
therefore, a considerable advantage in not requiring a
phantom to be scanned simultaneously with the patient. If
a phantom is not scanned simultaneously with the patient,
either a separate scan of a calibration phantom (asyn-
chronous calibration) must be performed, or an “internal”
or “phantom-less” calibration based on the Hounsfield units
of several tissues within the body may be applied.
Although previous studies have indicated that uncali-
brated Hounsfield units values from CT scanners may be
used for the opportunistic screening of low bone mass [4],
the use of a calibration standard means that the derived
aBMD results and T-score computations will be consistent
across CT scanners from different manufacturers and also
consistent at different scanning X-ray energies [25].Internal BMD calibration
The principal behind QCT utilizing internal calibration is to
use CT values of internal tissues as references for the BMD
calibration. In general, the method relies on the patient’s
paraspinal muscle and subcutaneous fat as calibration ref-
erences and uses the peak of a best-fit Gaussian distribution
to the muscle and fat histograms, respectively, for the
calibration [26].
Only two technical studies on the use of internal cali-
bration have been published, and both of these were of
measurement at the spine [26,27]. The original method
reported by Boden et al [27] was made commercially
available by IRIS Inc. (Myersville, MD, USA). This method has
been used by Gudmundsdottir et al [28] to investigate age-
related vertebral BMD changes in Icelandic women and by
Hopper et al [29] to explore the possibility of opportunistic
screening using contrast-enhanced and noncontrast
abdomen and pelvic scans. The method has been provided
as a QCT solution on Philips CT scanners (Philips Healthcare,
Cleveland, OH, USA) and has been used in this format by
Pickhardt et al [8] for opportunistic screening.
Despite the convenience of using an internal calibration
standard, there are some disadvantages to the method. The
reproducibility of external phantom systems is generally
superior to that of internal calibration systems because of
the underlying differences in muscle attenuation related to
variations in atrophy, fat infiltration, and hydration [26]. In
addition, although Weber et al [14] presented the use of CT
scans of inflammatory bowel disease patients for projec-
tional aBMD measurement at the hip, the internal reference
standards that were used are not described and no estab-
lished calibration standards for use at the pelvis for the
analysis of BMD at the proximal femur have yet been pre-
sented in peer-reviewed literature.
Asynchronous BMD calibration
An alternative to either simultaneous calibration or the use
of internal calibration standards is the method of using an
external calibration standard but scanned in an “asyn-
chronous” mode at a different time from the patient scan
[30]. In a recent study on asynchronous calibration [31], T-
scores derived from CTXA were compared with T-scores
obtained from DXA. Correlation between DXA and CTXA T-
scores was as high as the correlation of T-scores between
different DXA scanners, indicating that asynchronous cali-
bration of the CT images was very successful in that study.
The period between the CT scans of the patients and those
of the external calibration phantom were reported as being
approximately 4 years, which indicates good CT scanner
stability over this period.
Dual use of CT scans
The usual procedure for a producing a dedicated QCT hip
BMD acquisition uses an anterioreposterior computed
radiograph or localizer obtained by the scanner from the
iliac crest to a few centimetres past the lesser trochanter.
At the spine, a lateral localizer is used to define a volume
covering two contiguous vertebral levels. A contiguous
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femoral head to approximately 1 cm below the lesser
trochanter with a 2.5e3.0-mm slice thickness and spacing
between images. For opportunistic screening or dual use of
CT images, CT volume images may be sampled using soft-
ware tools such as SlicePick (Mindways Software Inc., Aus-
tin, TX, USA) to produce a simulated projection
anterioreposterior image to locate the femoral head and
lesser trochanter or to produce a simulated projection
lateral image to locate vertebral levels in the same way as
using a localizer. A contiguous set of slices is then chosen
covering this region for BMD analysis (Figure 6).
In the context of CTC screening, for which there is an
obvious overlap in the screened population due to age [12],
the changes required to normalize CTC workflow to facili-
tate QCT of the hip are easily accommodated and comprise
asynchronous calibration scans performed periodically
(e.g., monthly), ensuring that the CTC scan volume
appropriately includes the entire anorectal junction so that
the lesser trochanters are imaged, which is often a stan-
dard protocol in CTC imaging.
Influence of contrast media
Many of the existing CT abdominal and pelvic CT scans that
might be used for the diagnosis of low BMD have been ac-
quired after IV contrast administration. Because contrast
media increase X-ray absorption, it would be expected that
BMD values in perfused areas such as the trabecularFigure 6 A volume at the hip or spine may be manually
segmented from standard computed tomography scans
covering a region from the top of the acetabulum to below the
lesser trochanter, or a pair of contiguous vertebral levels, using
the SlicePick tool from Mindways.compartment of the vertebrae will increase, and QCT bone
density measurement is contraindicated for patients un-
dergoing IV contrast CT scans. While trabecular bone is
measured at the spine, projectional measurement of BMD
at the hip incorporates both cortical and trabecular bone.
Thus, it is generally expected that vBMD measurement by
QCT at the spine should be more affected than aBMD
measured by QCT at the hip.
Of the studies to date that investigated the feasibility of
dual use of CT images [4,7,8,13,14,26,29,31e33], around a
half have addressed the issue of dealingwith the potential for
IV contrast to increase BMD measurement [13,14,26,32,33].
Most of these previous studies on the effect of IV contrast on
QCT measurement have focused on BMD measurement at the
lumbar spine, and to date only a few studies have addressed
this issue at the hip [13,14,33]. In the study by Gruber et al
[33], the measurement made was volumetric BMD at the hip
and this was comparedwith DXAmeasurement. No projection
method was employed to measure a DXA-equivalent aBMD
from QCT data. Although both the other studies [13,14] did
produceaBMDmeasurementsbyprojection fromvQCT,Weber
etal [14] usedan internal calibration standard, andBaueretal
[13] used an external calibration standard within the patient
scan for simultaneous calibration.
The previous study by Bauer et al [13] used BMD mea-
surements obtained from vQCT of the spine and hip and
correlated them with those derived from nondedicated
contrast-enhanced standard CT data sets to derive a cali-
bration factor for vQCT. Based on linear regression, a cor-
relation coefficient of r Z 0.98 was calculated for lumbar
BMD with the equation BMD (QCT) Z 0.96  BMD (MDeCT)
e 20.9 mg/cm3. The investigators concluded that with the
conversion factors, reliable vBMD measurements can be
calculated for the spine from routine abdominal and pelvic
CT data sets. However, the absolute numbers show
considerable divergence because of the presence of the
contrast in the vertebral bone marrow.
Habashy et al [30] reported a similar additive bias of
20 mg/cm3 to 23 mg/cm3 in volumetric spine BMD estimates
for a paediatric population. This group reported a cross-
calibration equation including compensation for IV
contrast volume: BMD (QCT) Z BMD (with contrast) e
35.3 mg/cm3 þ 0.14 mg/cm3/mL  (IV contrast volume in
millilitre). A standard error of the estimate of 10.79 mg/
cm3 was reported for the prediction of standard externally
calibrated QCT BMD estimates from QCT BMD estimates
derived in the presence of IV contrast agent. Assuming a
standard deviation of 26 mg/cm3 for a 1 T-score unit change
implies a standard error of about 0.4 T-score units for this
standard error. This degree of uncertainty compares
favourably to a precision of 0.4 T-score units reported by
Kiebzak et al [36] for femoral neck T-scores obtained across
DXA units from different manufacturers. While evidence
exists supporting the notion of screening for low bone mass
based on lumbar spine QCT BMD estimates obtained in the
presence of IV contrast agent, this finding is tempered by
results from Acu et al [34] that show a significant time
dependency to such BMD measurements relative to the
time since IV contrast agent injection.
At the hip, Bauer et al [13] showed a coefficient of
r Z 0.99 with the equation BMD (QCT) Z 0.99  BMD
(MDCT) e 12 mg/cm2 (p < 0.01). In their study, Weber et al
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enterography-generated T-scores for femoral neck BMD
were highly correlated (R2 Z 0.84, p < 0.0001), with a
linear agreement and no significant offset from the origin.
Interestingly, the large study by Pickhardt et al. [4] based
on the use of CT values without any calibration stated that
IV contrast did not affect the ability of CT to distinguish
patients with low BMD from those with normal BMD.Conclusion
The potential clinical implications of extracting BMD data
from routine CT examinations are very wide ranging as
virtually any unenhanced abdominopelvic CT scan could
presumably be employed. Given the enormous patient
volume of body CT scanning currently performed in older
adults for a wide variety of clinical indications, this rep-
resents a unique opportunity to expand osteoporosis
screening. Importantly, this opportunistic screening re-
quires no additional patient time or radiation exposure, and
very little time from radiology staff, further enhancing the
clinical yield of the CT scan; and one clear advantage of CT
over DXA BMD screening is its ability to accurately identify
unsuspected osteoporotic compression fractures, which
clearly diagnose osteoporosis independent of the patient’s
DXA T-score [35].
Classically, QCT has utilized an in-scan phantom for
simultaneous calibration because of instabilities in CT
equipment. In particular, differences in table height from
scan to scan of a given patient can at least partly be
compensated with a simultaneous calibration. In the last
decade or so, CT scanner stability has improved a great
deal, which has led to the possibility of asynchronous
calibration methods. There are a number of potential
advantages in avoiding the need for the placement of a
calibration device beneath the patient by allowing for
calibration using a phantom to take place asynchronously.
Asynchronous calibration can achieve the following:
 Simplify radiology facility workflow by avoiding the need
for CT calibration phantom and table pad placement.
 Reduce the risk of needing to rescan a patient due to
improper placement of a CT calibration phantom.
 Reduce overall patient exposure to ionizing radiation by
combining a medically appropriate bone density study
with another medically necessary CT study utilizing the
same CT scan covering the abdomen (spine), pelvis
(proximal femur), or abdomen and pelvis.
 Allow for retrospective extraction of bone density in-
formation from CT scans of the abdomen and/or pelvis
acquired for other purposes, again resulting in an overall
reduction in exposure of a patient to ionizing radiation.
However, retrospective analysis of existing CT scans
must still be treated with some caution without some
knowledge of the scanner stability between patient and
phantom scans. Further investigation is required to assess
the impact that IV contrast might have on BMD measure-
ment by QCT evaluation at both the spine and the hip.
However, if the use of postcontrast CT scans can be vali-
dated for BMD evaluation, particularly for the use ofprojectional aBMD at the hipdfor which there appears to
be little or no significant changedthe clinical impact would
be accentuated even further.Conflicts of interest
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